BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  Saad, Everardo D.

Results 1-19 of 19 (Search time: 0.023 seconds).

Issue DateTitleContributor(s)TypeCat.
12023Trial Design for Cancer Immunotherapy: A Methodological ToolkitSaad, Everardo D.; Coart, Elisabeth; DELTUVAITE-THOMAS, Vaiva; GARCIA BARRADO, Leandro; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
22022Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyGoldberg, Richard M.; Adams, Richard; BUYSE, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; BURZYKOWSKI, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem , Eric; Matheson, Alastair; de Gramont, AimeryJournal ContributionA1
32022Surrogacy Beyond Prognosis: The Importance of “Trial-Level” SurrogacyBUYSE, Marc; Saad, Everardo D.; BURZYKOWSKI, Tomasz; Regan, Meredith M.; Sweeney, Christopher S.Journal ContributionA1
42021The Net Benefit of a treatment should take the correlation between benefits and harms into accountBUYSE, Marc; Saad, Everardo D.; Peron, Julien; Chiem, Jean-Christophe; De Backer, Mickael; Cantagallo, Eva; Ciani, OrianaJournal ContributionA1
52020Commentary on Bamat et alSaad, Everardo D.; BUYSE, MarcJournal ContributionA2
62020Central statistical monitoring of investigator-led clinical trials in oncologyBUYSE, Marc; Trotta, Laura; Saad, Everardo D.; Sakamoto, JunichiJournal ContributionA1
72020Statistical aspects in adjuvant and neoadjuvant trials for gastrointestinal cancer in 2020: focus on time-to-event endpointsSaad, Everardo D.; BUYSE, MarcJournal ContributionA1
82019Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysisSaad, Everardo D.; Squifflet, Pierre; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P.; Slamon, Dennis; Wolmark, Norman; BUYSE, MarcJournal ContributionA1
92019Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLCRutkowski, Jacek; Saad, Everardo D.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Jassem, JacekJournal ContributionA1
102018The search for surrogate endpoints for immunotherapy trialsBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA2
112018Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
122017Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapySaad, Everardo D.; BUYSE, MarcJournal ContributionA2
132017Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionBURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
142017Precision medicine needs randomized clinical trialsSaad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
152017Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid TumorsMichiels, Stefan; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
162017The impact of data errors on the outcome of randomized clinical trialsBUYSE, Marc; Squifflet, Pierre; Coart, Elisabeth; Quinaux, Emmanuel; Punt, Cornelis J. A.; Saad, Everardo D.Journal ContributionA1
172017Authors' Reply to Schoenfeld: "Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors"Michiels, Stefan; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
182016Neoadjuvant as Future for Drug Development in Breast Cancer-LetterBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA1
192015Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancerCiani, Oriana; BUYSE, Marc; Garside, Ruth; Peters, Jaime; Saad, Everardo D.; Stein, Ken; Taylor, Rod S.Journal ContributionA1